z-logo
open-access-imgOpen Access
Predictors of eligibility for reimbursement of antiviral treatment in HBe-Ag negative chronic hepatitis B patients with high ALT levels
Author(s) -
Esra Ataoğlu,
Ali Duman,
Hayriye Esra Ataoğlu,
Aslı Örmeci,
Şule Poturoğlu
Publication year - 2022
Publication title -
journal of surgery and medicine
Language(s) - English
Resource type - Journals
ISSN - 2602-2079
DOI - 10.28982/josam.1012592
Subject(s) - medicine , liver biopsy , gastroenterology , hbeag , reimbursement , hepatitis b virus , hepatitis b , hepatitis c , hepatology , biopsy , hbsag , immunology , virus , health care , economics , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here